Authors/Task Force Members: John J.V. McMurray (Chairperson) (UK)*, Stamatis Adamopoulos (Greece), Stefan D. Anker (Germany), Angelo Auricchio (Switzerland), Michael Bohm (Germany), Kenneth Dickstein (Norway), Volkmar Falk (Switzerland), Gerasimos Filippatos (Greece), Candida Fonseca (Portugal), Miguel Angel Gomez-Sanchez (Spain), Tiny Jaarsma (Sweden), Lars Køber (Denmark), Gregory Y.H. Lip (UK), Aldo Pietro Maggioni (Italy), Alexander Parkhomenko (Ukraine), Burkert M. Pieske (Austria), Bogdan A. Popescu (Romania), Per K. Rønnevik (Norway), Frans H. Rutten (The Netherlands), Juerg Schwitter (Switzerland), Petar Seferovic (Serbia), Janina Stepinska (Poland), Pedro T. Trindade (Switzerland), Adriaan A. Voors (The Netherlands), Faiez Zannad (France), Andreas Zeiher (Germany).

Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, Guy De Backer1 (Belgium), Helmut Gohlke1 (Germany), Ian Graham1 (Ireland), Zˇ eljko Reiner2 (Croatia), W.M. Monique Verschuren1 (The Netherlands), Christian Albus3 (Germany), Pascale Benlian1 (France), Gudrun Boysen4 (Denmark), Renata Cifkova5 (Czech Republic), Christi Deaton1 (UK), Shah Ebrahim1 (UK), Miles Fisher6 (UK), Giuseppe Germano1 (Italy), Richard Hobbs1,7 (UK), Arno Hoes7 (The Netherlands), Sehnaz Karadeniz8 (Turkey), Alessandro Mezzani1 (Italy), Eva Prescott1 (Denmark), Lars Ryden1 (Sweden), Martin Scherer7 (Germany), Mikko Syva¨nne9 (Finland), Wilma J.M. Scholte Op Reimer1 (The Netherlands), Christiaan Vrints1 (Belgium),
David Wood1 (UK), Jose Luis Zamorano1 (Spain), Faiez Zannad1 (France).

La dénervation rénale par voie endovasculaire est une méthode nouvelle pour laquelle une étude clinique randomisée a montré une baisse de la pression artérielle chez des hypertendus résistants aux médicaments antihypertenseurs.

Catheter-based renal denervation is a new method for disrupting renal sympathetic nerves in the adventitia of renal arteries. A randomized clinical trial showed a decrease in blood pressure (BP) in resistant hypertensive patients. To guide clinicians and interventional practitioners in the use of this new approach, the French Societies of Arterial Hypertension, Cardiology and Radiology decided to combine their expertise and propose a consensus document assessing the benefit/risk ratio of this technique in arterial hypertension.

Les progrès diagnostiques et thérapeutiques ont conduit à une amélioration de la survie des patients atteints de la plupart des maladies chroniques et en particulier des maladies cardiovasculaires en intégrant également les cardiopathies congénitales.

Par le Groupe Exercice Réadaptation Sport - Prévention (GERS-P)
Août 2011